In addition, a novel crosstalk between inflammatory and hypoxic TME was revealed to be associated with the PI3K/AKT/mTOR pathway [104], which can be regulated by ruscogenin to reduce the expression of VEGF and HIF-1α, among others, and thus inhibit HCC metastasis [105]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.